FDA Proposes Major Changes to Drug Manufacturing Registration Process
The FDA's proposed rule aims to modernize drug manufacturing registration, particularly for distributed models. This will simplify compliance for manufacturers and enhance supply chain transparency, impacting future contract obligations and vendor interactions.